Dr. Yisheng Lee was appointed chief medical officer at Foresee Pharmaceuticals Co. and Dr. David Lau was named senior vice president, NCE Preclinical and Clinical Development. Dr. Yisheng Lee will play a leading role in establishing strategies related to portfolio management, clinical trials, regulatory affairs, pharmacovigilance and risk management. He has  broad experience in clinical practice, medical education, and academic research, and will network with academic institutions and clinica...